1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > The Human Microbiome: Biomedical Implications and Birth of a Market - Overview, CHI Insight Pharma Reports

The Human Microbiome: Biomedical Implications and Birth of a Market - Overview, CHI Insight Pharma Reports

  • October 2014
  • -
  • Insight Pharma Reports
  • -
  • 94 pages

Summary

Table of Contents

Published in October, 2014, is Insight Pharma Reports’ The Human Microbiome: Biomedical Implications and Birth of a Market. This report covers the evolution of microbiome research and its growth in the commercial market. Specific areas of study include microbial ecology, systems biology, diet, diagnostics, contributions in health and disease, and infectious disease.

Microbiota have become a center for discussion and investigation after research has unraveled the symbiotic relationship between humans and their microbial counterparts, and the impact of the delicate balance of specific microbiota on various diseases. Such diseases include diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Irritable Bowel Diseases (IBD). Understanding how microbiota act as communities, and thus is relation to disease, has been the topic of choice, known as microbial ecology, for several researchers. It has been demonstrated that when in equilibrium with their environment, microbiota gain benefits from the host, which enables them to provide useful benefits themselves. However, when this balance is disrupted, the repercussions can have a negative impact on human health. For example, the use of antibiotics can lead to vaginal yeast infections in women. This is because antibiotics kill not only the build-up of the infectious bacteria, but also all the other bacteria around it that keeps the control of yeast in check. Destroying these bacteria leads to the overgrowth of yeast and thus yeast infections.

In addition to antibiotics disrupting the microbiome environment, diet is another factor that can pose as a problem. A diet high in carbohydrates can also cause yeast build-up because yeast feed on sugar. Diet can also create an imbalance in the microbiome environment and jeopardize the symbiotic relationship between the microbiota and the host. A simple difference between consuming plant fats vs. animals fats has been demonstrated to have an effect on the abundance of certain types of bacteria in the gut over others, suggesting that these bacteria may be linked to weight loss and/or gain. In fact, researchers concluded there was a link between people who had animal-based dietary fats, bile acids, and irritable bowel diseases. Due to these findings, researchers are further investigating the relation between microbiota and the impact on various immune pathways, and the influence on obesity and diabetes.
In addition to covering several aspects of the microbiome, the report also includes the impact of this rising field on commercial aspects and product development.

Companies covered in this space include:

4D Pharma
ActoGenixAOBiome
AvidBiotics
CIPAC Limited
Enterome Bioscience
Human Longevity
Metabiomics
Microbiome Therapeutics
Miomics
OmniBiome Therapeutics
OptiBiotix
Osel Inc
OxThera
PathoGenetix
Rebiotix
Ritter Pharmaceuticals
Second Genome
Seres Health
uBiome
UCB
UC San Francisco
Vedanta
ViThera Pharmaceuticals
Whole Biome

Final features of the report include:

In-depth analysis of market data
Exclusive interview transcripts with the following experts:
Peter DiLaura, President & CEO, Second Genome
Colleen Cutcliffe, CEO, Whole Biome
James Brown, PhD; Head, Computational Biology; Head, Microbiome Matrix Team; GlaxoSmithKline
Jack Gilbert, PhD., Environmental Microbiologist, Assoc. Prof., Department of Ecology & Evolution, Argonne National Laboratory
Glenn Tillotson, PhD, Senior Partner, Transcrip Partners, USA
Peter P. Lee, MD, Executive Chairman, Osel, Inc.
Gregory Kuehn, VP Business Development and Marketing, Metabiomics
Stephen Elms, CEO, Miomics Bio-Therapeutics
Sydney M. Finegold, M.D., Emeritus Professor of Medicine, and Emeritus Professor of Microbiology, Immunology, and Molecular Biology, UCLA School of Medicine; Staff Physician, Infectious Disease Section, VA Greater Los Angeles Healthcare System

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


Download Unlimited Documents from Trusted Public Sources

Mental Health Statistics in the US

  • April 2017
    6 pages
  • Mental Health  

  • United States  

View report >

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Mental Health Statistics in the US - Forecast

  • April 2017
    3 pages
  • Mental Health  

    Neurological Di...  

  • United States  

View report >

Obesity Statistics

8 days ago

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.